Short Interest in Haleon plc (NYSE:HLN) Expands By 5.8%

Haleon plc (NYSE:HLN) was the recipient of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 12,420,000 shares, an increase of 5.8% from the November 15th total of 11,740,000 shares. Approximately 0.3% of the company’s shares are sold short. Based on an average trading volume of 6,260,000 shares, the short-interest ratio is presently 2.0 days.

Haleon Trading Down 0.4 %

Shares of Haleon stock opened at $9.72 on Tuesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon has a 52 week low of $7.89 and a 52 week high of $10.80. The stock has a 50 day moving average price of $9.74 and a two-hundred day moving average price of $9.54. The stock has a market capitalization of $44.00 billion, a PE ratio of 28.59, a price-to-earnings-growth ratio of 2.95 and a beta of 0.28.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. UBS Group raised shares of Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Morgan Stanley raised their price target on shares of Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a report on Friday, September 20th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $10.95.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Blue Trust Inc. boosted its stake in Haleon by 30.0% during the 2nd quarter. Blue Trust Inc. now owns 24,734 shares of the company’s stock valued at $210,000 after purchasing an additional 5,712 shares during the last quarter. Raymond James & Associates boosted its stake in shares of Haleon by 14.7% in the 2nd quarter. Raymond James & Associates now owns 4,019,978 shares of the company’s stock worth $33,205,000 after buying an additional 515,651 shares during the last quarter. First Horizon Advisors Inc. grew its holdings in shares of Haleon by 11.6% in the second quarter. First Horizon Advisors Inc. now owns 15,104 shares of the company’s stock valued at $125,000 after acquiring an additional 1,568 shares in the last quarter. Fifth Third Bancorp increased its position in shares of Haleon by 8.2% during the second quarter. Fifth Third Bancorp now owns 374,010 shares of the company’s stock valued at $3,089,000 after acquiring an additional 28,394 shares during the last quarter. Finally, Aaron Wealth Advisors LLC lifted its holdings in Haleon by 16.3% during the second quarter. Aaron Wealth Advisors LLC now owns 23,735 shares of the company’s stock worth $196,000 after acquiring an additional 3,330 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.